Rosuvastatin Completed Phase 3 Trials for Dyslipidemias / Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT0065460248-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT03026933Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
NCT02586129Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
NCT02827903Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
NCT02126358Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
NCT00251680Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.